Leeward Investments LLC MA Has $14.63 Million Stock Position in Cabot Co. (NYSE:CBT)

Leeward Investments LLC MA trimmed its stake in Cabot Co. (NYSE:CBT - Free Report) by 6.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 160,246 shares of the specialty chemicals company's stock after selling 11,944 shares during the quarter. Leeward Investments LLC MA owned approximately 0.30% of Cabot worth $14,632,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in CBT. First Horizon Advisors Inc. grew its stake in shares of Cabot by 22.0% in the third quarter. First Horizon Advisors Inc. now owns 650 shares of the specialty chemicals company's stock valued at $73,000 after buying an additional 117 shares in the last quarter. GAMMA Investing LLC lifted its stake in Cabot by 10.7% in the fourth quarter. GAMMA Investing LLC now owns 1,348 shares of the specialty chemicals company's stock valued at $123,000 after acquiring an additional 130 shares during the last quarter. CWM LLC grew its position in shares of Cabot by 35.6% in the 3rd quarter. CWM LLC now owns 564 shares of the specialty chemicals company's stock valued at $63,000 after acquiring an additional 148 shares during the period. Moran Wealth Management LLC increased its stake in shares of Cabot by 0.3% during the 3rd quarter. Moran Wealth Management LLC now owns 62,116 shares of the specialty chemicals company's stock worth $6,943,000 after purchasing an additional 178 shares during the last quarter. Finally, M&T Bank Corp raised its holdings in shares of Cabot by 0.4% in the 3rd quarter. M&T Bank Corp now owns 50,221 shares of the specialty chemicals company's stock valued at $5,614,000 after purchasing an additional 213 shares during the period. Institutional investors and hedge funds own 93.18% of the company's stock.

Cabot Price Performance

Shares of NYSE CBT traded down $0.42 during mid-day trading on Wednesday, reaching $86.58. The company had a trading volume of 481,851 shares, compared to its average volume of 411,639. Cabot Co. has a one year low of $82.31 and a one year high of $117.46. The business's 50-day simple moving average is $88.87 and its 200 day simple moving average is $100.92. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.29 and a current ratio of 2.00. The firm has a market cap of $4.69 billion, a price-to-earnings ratio of 11.50, a PEG ratio of 0.74 and a beta of 1.19.

Cabot (NYSE:CBT - Get Free Report) last issued its quarterly earnings results on Monday, February 3rd. The specialty chemicals company reported $1.76 earnings per share for the quarter, topping analysts' consensus estimates of $1.74 by $0.02. Cabot had a net margin of 10.60% and a return on equity of 26.79%. On average, research analysts predict that Cabot Co. will post 7.57 earnings per share for the current fiscal year.

Cabot Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 14th. Stockholders of record on Friday, February 28th will be issued a dividend of $0.43 per share. The ex-dividend date is Friday, February 28th. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.99%. Cabot's dividend payout ratio (DPR) is currently 22.84%.

Cabot declared that its board has initiated a share buyback plan on Tuesday, December 3rd that allows the company to repurchase 10,000,000 outstanding shares. This repurchase authorization allows the specialty chemicals company to reacquire shares of its stock through open market purchases. Stock repurchase plans are usually an indication that the company's leadership believes its stock is undervalued.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on CBT shares. StockNews.com upgraded Cabot from a "hold" rating to a "buy" rating in a research note on Tuesday, February 18th. JPMorgan Chase & Co. lowered their price target on shares of Cabot from $105.00 to $85.00 and set an "underweight" rating on the stock in a research report on Friday, February 21st. Finally, Mizuho cut their price objective on shares of Cabot from $122.00 to $110.00 and set an "outperform" rating for the company in a report on Tuesday, January 7th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, Cabot currently has a consensus rating of "Hold" and a consensus target price of $97.00.

Cabot Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.